Invion Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IVX.AX research report →
Price Chart
About the company
Invion Limited, an Australian clinical-stage life sciences enterprise, is actively engaged in the research and development of photodynamic therapy (PDT) to address various cancer types. Its flagship offering, IVX-PDT, is a photosensitizer agent being developed to combat skin cancers alongside a range of solid tumors, including those affecting the lungs, prostate, ovaries, and mesothelioma. The company has forged a research and development alliance with the Hudson Institute of Medical Research, jointly pursuing R&D initiatives for its Photosoft technology across a broad spectrum of cancer treatments.
- CEO
- Thian Chew
- IPO
- 2010
- Employees
- 8
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on IVX.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.04M
- P/E
- -0.28
- PEG
- 0.01
- P/S
- 0.00
- P/B
- 0.55
- EV/EBITDA
- -0.88
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -150.48%
- ROIC
- -106.56%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-1,290,285-228.6%
- Op Income
- $-5,286,432
- Net Income
- $-8,807,732-56.5%
- EPS
- $-0.12-36.4%
- OCF Growth
- -23.6%
- FCF Growth
- +10.1%
- 52W High
- $0.14
- 52W Low
- $0.03
- 50D MA
- $0.04
- 200D MA
- $0.07
- Beta
- 0.43
- RSI (14)
- 43
- Avg Volume
- 80.64K
No earnings-call transcripts are available for IVX.AX yet.
- Free Float
- 60.1%
- Shares Outstanding
- 109.20M
- Float Shares
- 65.63M
Our IVX.AX coverage
Recent articles, reports, and earnings notes.
No research on IVX.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate IVX.AX report →